基本資料
種類: ETF
費用比率%: 0.35
資產淨值: 185.41
成立日期: 20/12/2011
 
分析
市值分佈:
91.94%
大市值
--
中市值
--
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 11/07/2026 05:59) 總持有投資項目: 21  
0%
 
100%
     10大 (70.13%)
代號 名稱 佔比% 持有日期
AMGNAmgen15.1430/06/2026
GILDGilead Sciences12.7530/06/2026
VRTXVertex Pharmaceuticals9.1330/06/2026
REGNRegeneron Pharmaceuticals6.2730/06/2026
RVMDRevolution Medicines5.4130/06/2026
SGEN--5.0530/11/2023
NTRANatera4.9230/06/2026
ARGXargenx SE4.8830/06/2026
IQVIQVIA Holdings4.2930/06/2026
ALNYAlnylam Pharmaceuticals3.7330/06/2026
BIIBBiogen3.6330/06/2026
MRNAModerna3.3430/06/2026
ONCBeOne Medicines Ltd2.8530/06/2026
UTHRUnited Therapeutics Corp2.8330/06/2026
INSMInsmed Incorporated2.6130/06/2026
INCYIncyte Corp2.5130/06/2026
NBIXNeurocrine Biosciences2.0930/06/2026
BNTXBioNTech SE American Depositary Share1.9630/06/2026
TECHBio-Techne Corp1.5430/06/2026
QGENQiagen NV1.0830/06/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.